当日盘中,梯瓦制药(TEVA)股价出现罕见大涨,一度飙升5.15%,报21.93美元/股,引发市场广泛关注。
消息面上,目前并未有梯瓦制药相关的重大利好发布。分析人士认为,该公司近期财报表现较为稳定,实现营收43.41亿美元,虽然净利润仍为负值,但公司正逐步恢复增长。另一方面,投资者对于该股长期增长前景充满信心,多家券商给予该股买入评级,也有助于股价上涨。
作为一家全球领先的仿制药制造企业,梯瓦制药在欧美日等主要市场都占据重要地位,除了传统仿制药业务外,公司还在中枢神经、呼吸和肿瘤等多个领域持续拓展创新业务。目前市场预期梯瓦制药仍有一定上涨空间,未来仍需持续关注其经营情况。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.